let me rephrase that slightly:
Unless a new CEO is installed, only the most minimal progress will be possible and huge opportunity's will continue to be squandered. The market has no faith left in this guy and it’s completely understandable.
wolgen has proven over the 20 plus years that he’s been in total control of SCENESSE that he doesn’t have the skills needed to unlock the extraordinary potential of this safe peptide and get it out to the millions who’s health would benefit significantly.
. A safe peptide that stimulates endogenous eupigment (natures sunscreen) offers once in a lifetime opportunity. Without switched on, driven, honest and intelligent management that extraordinary potential will never be realised unfortunately.
- Forums
- ASX - By Stock
- CUV
- Ann: Chair Letter to Shareholders
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.47%
!
$8.98
Ann: Chair Letter to Shareholders, page-61
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.